登录

E-Health Now Closes ¥10M Series A Financing

作者: Mailman 2021-05-06 09:41
华美浩联
https://www.huameihaolian.com/
企业数据由 动脉橙 提供支持
生命周期数智化健康管理服务提供商 | B轮 | 运营中
中国-北京
2023-05-30
融资金额:数千万人民币
东方国资
查看

(VCBeat) Apr. 23, 2021 -- Suzhou Haohai Medical Technology Co., Ltd. ("E-Health Now"), a wholly-owned holding company of Huaohai Medical, announced closing a Series A investment round of tens of millions led by Ventech China Asia SICAR with participation from some of the existing investors.


Aiming to break down the geographic barrier of high-quality oncology care, E-Health Now is the first platform that exclusively focuses on optimizing the management plans for cancer patients in China. From initial virtual tumor board joint consultations, treatments suggestions delivery, to follow-up cares, E-Health Now brings world-class cancer care to Chinese cancer patients. 


E-Health Now has a network of 800+ oncologists/hematologists in the U.S., working with 5 top academic institutions, a HIPAA compliant EHR platform, patented machine learning technology, and treatment centers that focus on several sub-specialties of oncology/hematology that has significant clinical gaps between China and the U.S. 


Founded by Wharton MBA, MD/MBA of the University of Pennsylvania, physician of Mayo clinic, and an experienced cloud system engineer, the company has brought hope to over hundreds of patients and has secured partnerships with over 13 prestigious hospitals throughout China (including PUMCH) to deliver the highest quality of oncology care.


E-Health Now connects the clinical end and the commercial end based on China's national conditions and constantly improves its health management service platform through digitalization and intelligence. The company has successfully created a one-stop service platform integrating the three major solutions, including international consultation, technology introduction and service network. Through the platform, patients can get cutting-edge and high-quality medical services globally without going abroad.


>>>>

About Ventech China


Located in Shanghai, Ventech China is a leading investment firm currently managing 4 USD funds and 2 RMB funds focusing on developing extraordinary opportunities in communities, E-commerce, Big data, AI and Fintech. Since 1998 when Ventech Capital was founded in France, it has enjoyed the reputation of 'Best Venture Capital in France'.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

2023数字医疗年度创新白皮书:近百政策及审批昭示落地加速,半数融资关联人工智能

【VB100】第六届未来医疗100强大会开启,在世界难题面前书写“中国故事”

如何让临床医生体验感满分?惠每科技提出了对CDSS产业的三点思考

【首发】对标联合健康,华美浩联完成数千万人民币A轮融资

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Ronovo Surgical Closes ¥100M Series A Financing

2021-05-06
下一篇

Innogen Completes A New Round of Financing, Led by KIP

2021-05-06